Intracellular distribution of anthracyclines in drug resistant cells

Area of Science:

• Cell Biology
• Pharmacology
• Cancer Research

Background:

• Multidrug resistance (MDR) in tumor cells hinders chemotherapy efficacy.
• Overexpressed drug transporters reduce intracellular drug accumulation in resistant cells.
• Intracellular drug distribution differs significantly between sensitive and resistant tumor cells.

Purpose of the Study:

• To investigate the intracellular accumulation and distribution of doxorubicin in sensitive and resistant tumor cells.
• To identify the cellular mechanisms underlying doxorubicin sequestration in resistant cells.
• To explore the role of the Golgi apparatus and P-glycoprotein in doxorubicin resistance.

Main Methods:

• Laser scanning confocal microscopy to track doxorubicin fluorescence in living cells.
• Flow cytometry for quantitative analysis of drug uptake and efflux.
• Immunocytochemistry to detect P-glycoprotein expression and localization.

Main Results:

• Doxorubicin preferentially accumulated in the Golgi apparatus of resistant tumor cells.
• The Golgi apparatus sequestered doxorubicin, preventing its access to nuclear targets.
• P-glycoprotein was localized in the Golgi apparatus of both drug-induced and intrinsic resistant cells.
• Melanoma cells, exhibiting intrinsic resistance, also showed Golgi-associated P-glycoprotein.

Conclusions:

• The Golgi apparatus plays a critical role in the intracellular distribution and sequestration of doxorubicin in resistant tumor cells.
• Golgi-localized P-glycoprotein contributes to doxorubicin resistance by facilitating intracellular drug sequestration.
• Targeting the Golgi apparatus or associated transporters may offer novel strategies to overcome chemotherapy resistance.